Alecnib (Alectinib) 150mg Capsules 56-Pack | Everest Bangladesh Generic Alecensa | GLT

Generic Information: Alecnib (Alectinib) — Bangladesh

Alecnib is Everest Pharmaceuticals Ltd.'s alectinib capsule — 150 mg per hard capsule, 56 capsules to a bottle — produced in Bangladesh under WHO-GMP-certified conditions. Bangladesh occupies a distinctive position in global oncology access: its national patent law has long allowed local manufacture of on-patent cancer medicines for domestic and named-patient supply, so companies like Everest industrialize world-class molecules years before they reach neighboring markets by conventional routes. Alecnib is that playbook applied to the most prescribed second-generation ALK inhibitor.

What Is Alecnib (Alectinib) Used For?

Everest's own package insert states the two registered uses plainly: first-line monotherapy for adults with ALK-positive advanced NSCLC, and treatment of adults with ALK-positive advanced NSCLC previously treated with crizotinib. Bangladeshi prescribing mirrors the global gate — a validated ALK rearrangement must be documented before the first capsule, because ALK-negative tumors derive no benefit. Regional buyers, from South Asia to Africa, request Alecnib as the affordable continuation of therapy when originator supply or budget runs out.

How Does Alecnib (Alectinib) Work?

The molecule is a potent, selective inhibitor of the ALK fusion kinase — with laboratory activity against RET kinase and against the panel of mutations through which tumors escape crizotinib. Downstream, ALK blockade collapses the STAT3 and PI3K/AKT signaling that the fusion protein keeps lit, pushing the tumor cell into apoptosis. Two engineered traits carry the clinical weight: the molecule is not expelled from the brain by P-gp/BCRP efflux pumps, so it controls intracranial disease, and its M4 metabolite is itself a strong ALK inhibitor, effectively doubling the pharmacologic strike.

Indications of Alecnib

Registered indications per the Everest insert: adult ALK-positive advanced NSCLC, first line; and the same population after crizotinib. Global labels add the adjuvant setting after resection of node-positive or larger tumors, which Bangladeshi oncologists reference as international practice. Nothing here extends to ALK-wildtype disease — the test report is the entry ticket, and Everest's own literature says so.

Dosage and Administration

The insert's arithmetic is worth learning once: 600 mg (four 150 mg capsules) twice daily with food — 1,200 mg a day — so a 56-capsule bottle covers exactly one week of therapy. Severe hepatic impairment (Child-Pugh C) starts at 450 mg twice daily; dose reductions descend by 150 mg steps to a floor of 300 mg twice daily, below which treatment stops. Capsules are swallowed whole with food; make up a missed dose unless the next one is within six hours, and never re-dose after vomiting.

Side Effects of Alecnib

Expect the international alectinib fingerprint, which Everest's insert reproduces: constipation, edema, fatigue, myalgia, anemia, rash and photosensitivity among the common; hepatotoxicity, ILD/pneumonitis, bradycardia, CPK elevation, hemolytic anemia and embryo-fetal harm among the serious. The monitoring rhythm that keeps it safe — liver panel and CPK every two weeks early, pulse and blood pressure at each visit, immediate imaging for new respiratory symptoms — costs little and catches almost everything. Patients of childbearing potential use effective contraception throughout and after therapy.

Storage Instructions

Store below 30°C in the original container, dry and protected from light; the bottle is a month-by-month companion, so keep the cap closed and the desiccant in place. No refrigeration. Out of children's reach, and expired capsules go to a pharmacy for disposal.

Why Choose Alecnib from GLT?

Everest is one of Bangladesh's export-oriented generics houses with a documented oncology line, and Alecnib arrives with batch documentation GLT verifies before dispatch. The economics are the headline: at the standard eight-capsules-per-day schedule, originator US-channel supply prices out at several multiples of the Bangladeshi generic for the same month — GLT quotes Alecnib routinely around roughly 70%–80% below US list for equivalent therapy. Whether you are a family buying one bottle or an institution tendering by the carton, the workflow is the same: verified stock, export paperwork, and a named human on WhatsApp +86 15234153837 / [email protected].

How to Order Alecnib (Alectinib)

Message the product and quantity, receive a written quotation with courier and payment options, confirm, and GLT dispatches with complete documentation — CoA and batch photographs available to institutional buyers before payment. WhatsApp +86 15234153837 and [email protected] are answered daily; recurring weekly-to-monthly bottle schedules can be pre-booked so therapy never gaps.

FAQ

Is Alecnib approved anywhere? It is registered in Bangladesh under the national regulatory pathway that governs local oncology generics; GLT supplies it for personal-import markets where that pathway is recognized.

How many bottles make a month? Four and a fraction — the schedule uses eight capsules daily and a bottle holds 56, so most clients take a monthly pack of five bottles to keep a buffer.

How does it compare with Alecensa? Same molecule, same 150 mg strength, different manufacturer and price; clinical expectations for response are the same.

What if I already take crizotinib? Alecnib's registered uses include the post-crizotinib setting — discuss the switch timing with your oncologist.

Do you ship Alecnib worldwide? GLT ships to most countries with full export documents; ask us about your destination before ordering.